Kenneth B Lee Jr's Net Worth
$76.2 Million
Who is Kenneth B Lee Jr?
Kenneth B Lee Jr has an estimated net worth of $76.2 Million. This is based on reported shares across multiple companies, which include BIOCRYST PHARMACEUTICALS INC, PhaseBio Pharmaceuticals Inc, EYENOVIA, INC., Aralez Pharmaceuticals Inc., Clearside Biomedical, Inc., MAXYGEN INC, OSI PHARMACEUTICALS INC, INSPIRE PHARMACEUTICALS INC, G1 Therapeutics, Inc., POZEN INC /NC, ABGENIX INC, and CV THERAPEUTICS INC.
SEC CIK
Kenneth B Lee Jr's CIK is 0001208570
Past Insider Trading and Trends
2009 was Kenneth B Lee Jr's most active year for acquiring shares with 16 total transactions. Kenneth B Lee Jr's most active month to acquire stocks was the month of May. 2018 was Kenneth B Lee Jr's most active year for disposing of shares, totalling 34 transactions. Kenneth B Lee Jr's most active month to dispose stocks was the month of April. 2016 saw Kenneth B Lee Jr paying a total of $3,659,401.02 for 3,894,853 shares, this is the most they've acquired in one year. In 2018 Kenneth B Lee Jr cashed out on 3,112,259 shares for a total of $40,330,362.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +32.13% | 16.75K |
—
|
—
| 68.86K |
Jun 13
| |||
Form 4
| +40.41% | 15K |
$1.71 | $25,650.00 | 52.12K |
Jan 31
| |||
Form 4
| +53.05% | 12.87K |
—
|
—
| 37.12K |
Jun 7
| |||
Form 4
| +59.01% | 9K |
$9.29 | -$43,800.00 | 24.25K |
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +48.77% | 5K |
$1.45 | $7,250.00 | 15.25K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
∞
| 10.25K |
$8.24 | -$73,634.25 | 10.25K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.46M |
$5.00 |
—
| 2.46M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EYENOVIA, INC. (EYEN) Snapshot price: $1.775
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52.51% | 22.22K |
—
|
—
| 64.54K |
Jun 16
| |||
Form 4
| +30.94% | 10K |
$2.20 | $22,000.00 | 42.32K |
May 19
| |||
Form 4
| +27.46% | 6.96K |
—
|
—
| 32.32K |
Nov 17
| |||
Form 4
| +30.99% | 6K |
$5.42 | $32,512.00 | 25.36K |
Jun 11 - Jun 15
| |||
Form 4
| +60.38% | 7.29K |
—
|
—
| 19.36K |
Sep 11
| |||
Form 4
| +199.31% | 8.04K |
—
|
—
| 12.07K |
Aug 16
| |||
Form 4
|
∞
| 4.03K |
—
|
—
| 4.03K |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aralez Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.86% | 7.5K |
—
|
—
| 102.95K |
May 11
| |||
Form 4
| +5.53% | 5K |
$2.52 | $12,618.50 | 95.45K |
Mar 15
| |||
Form 4
| +1.12% | 1K |
$4.95 | $4,950.00 | 90.45K |
Nov 14
| |||
Form 4
| +9.15% | 7.5K |
—
|
—
| 89.45K |
Jun 16
| |||
Form 4
| -1.68% | -1.40K |
$3.58 | -$5,026.32 | 81.95K |
Jun 10
| |||
Form 4
| +1.21% | 1K |
$3.50 | $3,500.00 | 83.36K |
May 13
| |||
Form 4
|
∞
| 72.97K |
—
|
—
| 72.97K |
Feb 5
| |||
| No matching records found | |||||||||
Clearside Biomedical, Inc. (CLSD) Snapshot price: $1.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.42% | -29.66K |
$8.63 | -$255,784.88 | 2.06M |
Jan 17 - Jan 19
| |||
Form 4
| -1.42% | -25.30K |
$8.63 | -$218,222.36 | 1.76M |
Jan 17 - Jan 19
| |||
Form 4
| +3,082.66% | 1.73M |
$6.41 | -$483.00 | 1.78M |
Jun 7
| |||
Form 4
| +3,630.78% | 2.03M |
$6.83 | -$483.00 | 2.09M |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||